This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Kariyawasam, S. H. Articles by Jayawardane, P. Search for Related Content PubMed PubMed Citation Articles by Kariyawasam, S. H. Articles by Jayawardane, P. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Attention Deficit Hyperactivity Disorder Hazardous Substances DB METHYLPHENIDATE Social Bookmarking                         What's this?

Methylphenidate in Children With Attention-Deficit Hyperactivity Disorder (ADHD): Experience from a Sri Lankan Tertiary Children's Hospital

Department of Pharmacology Faculty of Medicine, University of Sri Jayawardanepura, Sri Lanka, kariyash{at}lycos.com

Hemamali Perera, MDPsych, MRCPsych

Department of Psychological Medicine University of Colombo, Sri Lanka

Anusha Koralagama, MBBS

Out Patients' Department, Peripheral Hospital Anamaduwa, Sri Lanka

Pradeepa Jayawardane, MBBS

Faculty of Medicine, University of Sri Jayawardanepura, Sri Lanka

The response to methylphenidate was assessed in children diagnosed as having attention-deficit hyperactivity disorder (ADHD) in 2000 at the Lady Ridgeway Tertiary Hospital for Children in Sri Lanka. They were managed in outpatient child psychiatry clinics. ADHD was diagnosed according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV). The severity of the symptoms was determined with a validated Sinhala assessment form based on DSM-IV criteria. The data on problems experienced by the diagnosed children and their families were obtained using an interviewer-administered questionnaire. The severity of the symptoms and problems experienced by the children and their families were reassessed at 6 weeks and 6 months of methylphenidate therapy. Thirty-seven new subjects were diagnosed as having ADHD in 2000, and 36 of them were treated with methylphenidate. The severity of the symptoms and the number of subjects receiving frequent complaints from school were significantly lower 6 weeks after methylphenidate treatment. At 6 months of treatment, the severity of the symptoms was not significantly reduced when compared with the severity assessed 6 weeks after treatment. Methylphenidate did help with school-related problems in the short term, but the long-term effects of methylphenidate were not convincing in this group of subjects and showed poor long-term compliance, probably owing to inadequate improvement seen in symptoms. (J Child Neurol 2005;20:496—499).

Journal of Child Neurology, Vol. 20, No. 6, 496-499 (2005)
DOI: 10.1177/08830738050200060501


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?